Careers in MSD Ireland
Benefits & rewards
Benefits & rewards
At MSD, our people are the driving force in everything we do. We know good health goes beyond physical well-being to include emotional, social and financial well-being so we offer a comprehensive benefits package and best-in-class approach to wellness for our employees.
Competitive base salary
Company pension scheme
Education assistance programme
Employee training programmes
World-class, state-of-the-art facilities
Health insurance
Opportunity to earn bonuses
Profit sharing (share purchase scheme)
Our operations are based throughout Ireland, with sites in Carlow, Cork, Dublin, Meath and Tipperary
Brinny, Co. Cork
This site has been a vibrant part of the pharmaceutical sector in Cork for over 35 years. With a successful legacy of developing and commercially supplying biotech products, Brinny is now specialising in the development and manufacture of innovative novel vaccines and testing of immuno-oncology medicines.
Ballydine
Opened in 1976 and currently employs 500 highly skilled people. The site has API and Formulation facilities for the manufacture and the development of new products. Work relating to 20 of MSD’s pipeline products is undertaken at this state-of-the-art research and commercialisation facility.
Carlow
Opened in 2008 as MSD’s first vaccines facility outside of the US. Carlow is the filling site for the liquid form of our immuno-oncology treatment for the global market. We are currently working on the construction of a second manufacturing facility that will focus on the production of vaccines and biologics.
Red Oak North in Dublin
The base for our Animal Health and Human Health businesses as well as a number of global and national support services including Clinical Research, Medical Affairs, Regulatory Affairs, Sales, Policy & Communications and Marketing.
Learn more about our Animal Health & Human Health Divisions
Learn more about our Animal Health & Human Health Divisions
Biotech, Dublin
This site will play a pivotal role in the manufacture of MSD’s biologics-based medicines, including in the area of immuno-oncology, and will expand MSD’s current internal network of biologics drug substance manufacturing plants when full manufacturing operations begin in 2021.
Dunboyne
The latest addition to the MSD, Ireland family is Dunboyne which joined our network in September 2020. With a team of over 200, this site will be MSD’s first Biologics Drug Substance single use commercialization facility, playing an important role in helping us commercialise key medicines.
